Today, I'm reviewing two articles that I personally found interesting when I was researching about Rheumatoid Arthritis!!
The first article that I found interesting was about the proteomic analysis to define the predictors of some treatment options in RA patients. Even though this whole article talked about many other common treatment options, the main treatments included the use of adalimumab or methotrexate. In this article, the researchers used a multiplex bead-based approach where they analyzed the healthy controls as well as the RA patients for their similarities and differentiation in the autoantibody expression and the co-expression profiles to test the outcome of their treatment. Also if any of the autoantibodies expressed are the response from the treatment. For this study, the healthy controls were selected from the specimens from blood donors of Bavarian Red Cross, Germany, and the experimental subjects were 18 years or older RA patients commencing Methotrexate along with other DMARDS and oral steroids from the Rheumatoid Arthritis medication study. The other set of experimental subjects were RA patients commencing adalimumab which is an anti-tumor necrosis factor (TNF) used to treat the inflammation in the joints. Out of 376 autoantibodies tested 39 autoantibodies were expressed differentially in the patients with Rheumatoid arthritis when compared with the healthy controls and most of them were in a citrullinated form. The patients who tested seropositive for citrullinated form had an improved DAS28, whereas, patients with seronegative citrullinated form tend to get a worsen DAS28 in their first 3 to 6 months of treatment.
This article is a peer reviewed article which was published in Pharmacogenomics journal in December 10, 2019 by the authors Stephanie F. Ling, Nisha Nair, Suzanne M. M. Verstappen, Anne Barton, Hans-Dieter Zucht, Petra Budde, Peter Schulz-Knappe, MATURA consortium, and, Darren Plant.
The second article I read was about a small study conducted to study the perspectives of Primary Care Physicians when dealing with RA patients. For this study, the researchers randomly selected PCPs practicing in the United States. As part of the study, they conducted a survey via email which included questions about their experiences with the RA patients, how comfortable they are, rheumatological referrals, and their prescribing of the disease-modifying anti-rheumatic drugs (DMARDS drugs). The main goal of this study was to check and understand the experiences, attitudes, knowledge about how these PSPs have with the Rheumatoid arthritis patients since these were the doctors who get the first contact with the patients. There were also some complaints raised by the RA patients about how much care they receive from the PCPs and Rheumatologists. Therefore, this survey to a certain extent I believe was able to capture some insights about the treatments, attitudes, and experience of some PCPS. The study recorded that around 1,103 PCPs opened the survey but only 267 PCPs completed the survey. It was mostly men with an experience of 10 years having six RA patients completed this survey. It was interesting that only half of the doctors receive training for treating RA patients after their medical school years and out of this only one-third were confident in their treatment. Overall, from the study, it was clear that most of the PCPs weren't comfortable treating RA patients either due to lack of confidence and/or lack of experience.
This article is also a peer-reviewed article written by Katie L Garneau, Mura D Iversen, Hsun Tsao & Daniel H Solomon published by Department of Physical Therapy School of Health Professions, Bouve College of Health Sciences Northeastern University on the November 18th, 2011.
Citation:
Ling, S.F., Nair, N., Verstappen, S.M.M. et al. Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients. Pharmacogenomics J20, 516–523 (2020). https://doi.org/10.1038/s41397-019-0139-4
Garneau, K.L., Iversen, M.D., Tsao, H. et al. Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement. Arthritis Res Ther 13, R189 (2011). https://doi.org/10.1186/ar3517